Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefdinir Granules

Approval Number

国药准字H20243151

Company海南葫芦娃药业集团股份有限公司

Registration Date

February 6, 2024

Drug Information

Generic Name

头孢地尼颗粒

Dosage Form

颗粒剂

Strength

50mg

Drug Type

化学药品

Registration Date

February 6, 2024

Company Information

Applicant Company

Company Name海南葫芦娃药业集团股份有限公司

Company Address

海南省海口市海口国家高新区药谷工业园二期药谷四路8号

Manufacturing Company

Company Name海南葫芦娃药业集团股份有限公司

Company Address

海口保税区6号厂房西B区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy